Short on Competition Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
The bill reduces a compliance mandate, trade restriction, definition change provision: 2 and adds or tightens a compliance mandate, trade restriction, definition change provision: 506C–2. It relies on compliance mandates, trade restrictions, and definition changes. The main policy areas are Healthcare.
Who Benefits and How
The available clause analysis does not identify a specific beneficiary group.
Who Bears the Burden and How
No clear private burden is identified from the available clause analysis; implementing agencies may still take on administrative work.
Key Provisions
- Reduces a compliance mandate, trade restriction, definition change provision: 2.
- Adds or tightens a compliance mandate, trade restriction, definition change provision: 506C–2.
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for primary purpose and policy domains.
At a Glance
What This Bill Does
The bill reduces a compliance mandate, trade restriction, definition change provision: 2 and adds or tightens a compliance mandate, trade restriction, definition change provision: 506C–2.
Key Policy Areas
Healthcare
Primary Purpose
The bill reduces a compliance mandate, trade restriction, definition change provision: 2 and adds or tightens a compliance mandate, trade restriction, definition change provision: 506C–2.
Policy Domains
Sponsors
Legislative Progress
In CommitteeMs. Klobuchar (for herself, Mr. Lee, Mr. Durbin, and Mr. …
Read twice and referred to the Committee on Health, Education, …
Introduced in Senate
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
Key Definitions
Terms defined in this bill
a drug that is not a radio pharmaceutical drug product or any other product as designated by the Secretary.. (iii)the number of drugs authorized for temporary importation under section 506C(h)
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology